{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:41:43Z","timestamp":1776620503446,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/bmt.2015.64","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T13:33:28Z","timestamp":1427722408000},"page":"954-960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center"],"prefix":"10.1038","volume":"50","author":[{"given":"W P","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Dorostkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"key":"BFbmt201564_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/107327481101800405","volume":"18","author":"E Ayala","year":"2011","unstructured":"Ayala E, Tomblyn M . Hematopoietic cell transplantation for lymphomas. Cancer Control 2011; 18: 246\u2013257.","journal-title":"Cancer Control"},{"key":"BFbmt201564_CR2","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.bbmt.2011.10.035","volume":"18","author":"PA Carpenter","year":"2012","unstructured":"Carpenter PA, Meshinchi S, Davies SM . Transplantation for AML in children. Biol Blood Marrow Transplant 2012; 18: S33\u2013S39.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201564_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pcl.2010.01.002","volume":"57","author":"P Mehta","year":"2010","unstructured":"Mehta P, Locatelli F, Stary J, Smith FO . Bone marrow transplantation for inherited bone marrow failure syndromes. Pediatr Clin North Am 2010; 57: 147\u2013170.","journal-title":"Pediatr Clin North Am"},{"key":"BFbmt201564_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jpeds.2007.04.054","volume":"151","author":"PJ Orchard","year":"2007","unstructured":"Orchard PJ, Blazar BR, Wagner J, Charnas L, Krivit W, Tolar J . Hematopoietic cell therapy for metabolic disease. J Pediatr 2007; 151: 340\u2013346.","journal-title":"J Pediatr"},{"key":"BFbmt201564_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1053\/j.seminhematol.2009.10.001","volume":"47","author":"AR Smith","year":"2010","unstructured":"Smith AR, Gross TG, Baker KS . Transplant outcomes for primary immunodeficiency disease. Semin Hematol 2010; 47: 79\u201385.","journal-title":"Semin Hematol"},{"key":"BFbmt201564_CR6","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/j.bbmt.2011.10.023","volume":"18","author":"J Tolar","year":"2012","unstructured":"Tolar J, Mehta PA, Walters MC . Hematopoietic cell transplantation for nonmalignant disorders. Biol Blood Marrow Transplant 2012; 18: S166\u2013S171.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201564_CR7","unstructured":"National Marrow Donor Program [internet]. Minneapolis: National Marrow Donor Program; c.1996\u20132014 [cited 2014 Dec]. Available from http:\/\/www.marrow.org."},{"key":"BFbmt201564_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/9781444303537","volume-title":"Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation","author":"FR Appelbaum","year":"2009","unstructured":"Appelbaum FR, Thomas E . Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation. 4th edn Wiley-Blackwell: Oxford, UK, 2009."},{"key":"BFbmt201564_CR9","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","volume":"25","author":"E Robenshtok","year":"2007","unstructured":"Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 2007; 25: 5471\u20135489.","journal-title":"J Clin Oncol"},{"key":"BFbmt201564_CR10","first-page":"560","volume":"5","author":"A Alousi","year":"2007","unstructured":"Alousi A, de Lima M . Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Clin Adv Hematol Oncol 2007; 5: 560\u2013570.","journal-title":"Clin Adv Hematol Oncol"},{"key":"BFbmt201564_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/sj.bmt.1705923","volume":"41","author":"P Satwani","year":"2008","unstructured":"Satwani P, Cooper N, Rao K, Veys P, Amrolia P . Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 2008; 41: 173\u2013182.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201564_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2141.2010.08224.x","volume":"150","author":"BE Shaw","year":"2010","unstructured":"Shaw BE, Arguello R, Garcia-Sepulveda CA, Madrigal JA . The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. Br J Haematol 2010; 150: 251\u2013258.","journal-title":"Br J Haematol"},{"key":"BFbmt201564_CR13","unstructured":"Mohty M, Malard F, Savani BN . High-dose total body irradiation and myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink? Biol Blood Marrow Transplant 2014 e-pub ahead of print, 20 September 2014: doi: 0.1016\/j.bbmt.2014.09.010."},{"key":"BFbmt201564_CR14","first-page":"443","volume-title":"Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition","author":"KG Blume","year":"2004","unstructured":"Blume KG, Krance RA . The evaluation and counseling of candidates for hematopoietic cell transplantation. Appelbaum FR, Forman SJ, Negrin RS, Blume KG (eds.) Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. Wiley-Blackwell: Hoboken, NJ, USA, 2004, 443\u2013460."},{"key":"BFbmt201564_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3949\/ccjm.75.8.591","volume":"75","author":"E Levine","year":"2008","unstructured":"Levine E, Rosero SZ, Budzikowski AS, Moss AJ, Zareba W, Daubert JP . Congenital long QT syndrome: considerations for primary care physicians. Cleve Clin J Med 2008; 75: 591\u2013600.","journal-title":"Cleve Clin J Med"},{"key":"BFbmt201564_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jelectrocard.2005.06.008","volume":"38","author":"RS Lankipalli","year":"2005","unstructured":"Lankipalli RS, Zhu T, Guo D, Yan GX . Mechanisms underlying arrhythmogenesis in long QT syndrome. J Electrocardiol 2005; 38: 69\u201373.","journal-title":"J Electrocardiol"},{"key":"BFbmt201564_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cpcardiol.2008.07.002","volume":"33","author":"I Goldenberg","year":"2008","unstructured":"Goldenberg I, Zareba W, Moss AJ . Long QT Syndrome. Curr Probl Cardiol 2008; 33: 629\u2013694.","journal-title":"Curr Probl Cardiol"},{"key":"BFbmt201564_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden DM . Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350: 1013\u20131022.","journal-title":"N Engl J Med"},{"key":"BFbmt201564_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.hrthm.2009.08.005","volume":"7","author":"AS Amin","year":"2010","unstructured":"Amin AS, Tan HL, Wilde AA . Cardiac ion channels in health and disease. Heart Rhythm 2010; 7: 117\u2013126.","journal-title":"Heart Rhythm"},{"key":"BFbmt201564_CR20","first-page":"523","volume":"14","author":"W Zareba","year":"2007","unstructured":"Zareba W . Drug induced QT prolongation. Cardiol J 2007; 14: 523\u2013533.","journal-title":"Cardiol J"},{"key":"BFbmt201564_CR21","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"},{"key":"BFbmt201564_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","volume":"16","author":"DY Lin","year":"1997","unstructured":"Lin DY . Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16: 901\u2013910.","journal-title":"Stat Med"},{"key":"BFbmt201564_CR23","unstructured":"Credible Meds [internet]. 2014. AZCERT, Inc.: Oro Valley, AZ, USA, (accessed 2014 Oct). Available from: http:\/\/www.crediblemeds.org."},{"key":"BFbmt201564_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1542-474X.2009.00345.x","volume":"15","author":"AJ Moss","year":"2010","unstructured":"Moss AJ . Gender differences in ECG parameters and their clinical implications. Ann Noninvasive Electrocardiol 2010; 15: 1\u20132.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"BFbmt201564_CR25","doi-asserted-by":"publisher","first-page":"23B","DOI":"10.1016\/0002-9149(93)90036-C","volume":"72","author":"AJ Moss","year":"1993","unstructured":"Moss AJ . Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993; 72: 23B\u201325B.","journal-title":"Am J Cardiol"},{"key":"BFbmt201564_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0022-3476(84)80026-8","volume":"105","author":"KS Bender","year":"1984","unstructured":"Bender KS, Shematek JP, Leventhal BG, Kan JS . QT interval prolongation associated with anthracycline cardiotoxicity. J Pediatr 1984; 105: 442\u2013444.","journal-title":"J Pediatr"},{"key":"BFbmt201564_CR27","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1200\/JCO.1993.11.10.1906","volume":"11","author":"CL Schwartz","year":"1993","unstructured":"Schwartz CL, Hobbie WL, Truesdell S, Constine LC, Clark EB . Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. J Clin Oncol 1993; 11: 1906\u20131910.","journal-title":"J Clin Oncol"},{"key":"BFbmt201564_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/157488610789869111","volume":"5","author":"C Bagnes","year":"2010","unstructured":"Bagnes C, Panchuk PN, Recondo G . Antineoplastic chemotherapy induced QTc prolongation. Curr Drug Saf 2010; 5: 93\u201396.","journal-title":"Curr Drug Saf"},{"key":"BFbmt201564_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cpcardiol.2008.01.002","volume":"33","author":"SW Yusuf","year":"2008","unstructured":"Yusuf SW, Razeghi P, Yeh ET . The diagnosis and management of cardiovascular disease in cancer patients. Curr Probl Cardiol 2008; 33: 163\u2013196.","journal-title":"Curr Probl Cardiol"},{"key":"BFbmt201564_CR30","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1158\/1078-0432.CCR-08-0308","volume":"14","author":"M Hazarika","year":"2008","unstructured":"Hazarika M, Jiang X, Liu Q, Lee SL, Ramchandani R, Garnett C et al. Tasigna for chronic and accelerated phase Philadelphia chromosome\u2014positive chronic myelogenous leukemia resistant to or intolerant of imatinib. Clin Cancer Res 2008; 14: 5325\u20135331.","journal-title":"Clin Cancer Res"},{"key":"BFbmt201564_CR31","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/cncr.24927","volume":"116","author":"FM Johnson","year":"2010","unstructured":"Johnson FM, Agrawal S, Burris H, Rosen L, Dhillon N, Hong D et al. Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors. Cancer 2010; 116: 1582\u20131591.","journal-title":"Cancer"},{"key":"BFbmt201564_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ijantimicag.2009.05.009","volume":"34","author":"W Manosuthi","year":"2009","unstructured":"Manosuthi W, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Nolen TL, Zimmer LO et al. Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis. Int J Antimicrob Agents 2009; 34: 494\u2013496.","journal-title":"Int J Antimicrob Agents"},{"key":"BFbmt201564_CR33","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1086\/423275","volume":"39","author":"Y Alkan","year":"2004","unstructured":"Alkan Y, Haefeli WE, Burhenne J, Stein J, Yaniv I, Shalit I, Voriconazole-induced QT . interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect. Clin Infect Dis 2004; 39: e49\u2013e52.","journal-title":"Clin Infect Dis"},{"key":"BFbmt201564_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1203\/01.pdr.0000190579.24054.39","volume":"59","author":"E Braunlin","year":"2006","unstructured":"Braunlin E, Mackey-Bojack S, Panoskaltsis-Mortari A, Berry JM, McElmurry RT, Riddle M et al. Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome. Pediatr Res 2006; 59: 27\u201332.","journal-title":"Pediatr Res"},{"key":"BFbmt201564_CR35","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.hrthm.2009.05.006","volume":"6","author":"K Porthan","year":"2009","unstructured":"Porthan K, Viitasalo M, Jula A, Reunanen A, Rapola J, V\u00e4\u00e4n\u00e4nen H et al. Predictive value of electrocardiographic QT interval and T-wave morphology parameters for all-cause and cardiovascular mortality in a general population sample. Heart Rhythm 2009; 6: 1202\u20131208.","journal-title":"Heart Rhythm"},{"key":"BFbmt201564_CR36","first-page":"309","volume":"1","author":"AJ Moss","year":"1992","unstructured":"Moss AJ, Robinson JL . Long QT syndrome. Heart Dis Stroke 1992; 1: 309\u2013314.","journal-title":"Heart Dis Stroke"},{"key":"BFbmt201564_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.20042","volume":"76","author":"H Nakamae","year":"2004","unstructured":"Nakamae H, Hino M, Akahori M, Terada Y, Yamane T, Ohta K et al. Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation. Am J Hematol 2004; 76: 1\u20137.","journal-title":"Am J Hematol"},{"key":"BFbmt201564_CR38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1399-3046.2010.01389.x","volume":"14","author":"N Motoki","year":"2010","unstructured":"Motoki N, Shimizu T, Akazawa Y, Saito S, Tanaka M, Yanagisawa R et al. Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 2010; 14: 986\u2013992.","journal-title":"Pediatr Transplant"},{"key":"BFbmt201564_CR39","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.amjcard.2009.05.040","volume":"104","author":"YB Goldsmith","year":"2009","unstructured":"Goldsmith YB, Liu J, Chou J, Hoffman J, Comenzo RL, Steingart RM . Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring. Am J Cardiol 2009; 104: 990\u2013994.","journal-title":"Am J Cardiol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201564","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:26:29Z","timestamp":1648063589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,30]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["BFbmt201564"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.64","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,30]]},"assertion":[{"value":"20 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}